Aug 2026· Revista ft· Vol 30, pp. 01-18· 0 citations· 1 references
TL;DR
It is concluded that the association between hypertension and chronic kidney disease requires individualized protocols, educational actions, and early screening in order to improve blood pressure control, preserve renal function, and reduce morbidity and mortality in the elderly.
Abstract
Systemic arterial hypertension (SAH) and chronic kidney disease (CKD) are among the most prevalent chronic conditions in the elderly, frequently coexisting and mutually exacerbating their outcomes. This interaction compromises quality of life and increases the risk of cardiovascular and renal complications, making its management a significant challenge. This study analyzed the influence of hypertension on the progression of kidney disease in the elderly and evaluated the effectiveness of available therapeutic strategies. This is a qualitative bibliographic research, based on studies published between 2015 and 2025 in the PubMed, SciELO, LILACS, and CINAHL databases, including full articles in Portuguese, English, and Spanish that addressed the coexistence of SAH and CKD in the elderly. The findings indicate that poorly controlled hypertension is the main factor in the progression of CKD, whose asymptomatic nature favors late diagnosis and increased complications. Therapeutic strategies such as ACE inhibitors, ARBs, diuretics, and non-pharmacological measures proved effective; However, low adherence, polypharmacy, and limitations in follow-up reduce its effectiveness. It is concluded that the association between hypertension and chronic kidney disease requires individualized protocols, educational actions, and early screening in order to improve blood pressure control, preserve renal function, and reduce morbidity and mortality in the elderly.
Pulmonary arterial hypertension is a progressive and serious disease characterized by pulmonary vascular remodeling and subsequent right ventricular failure. In Argentina, the management of this condition faces significant health challenges, evidenced by diagnostic delays, under-utilization of recommended therapies, an...
M. L. Coronel, Guillermina Sorasio, J. P. Casas et al.· Revista de la Federación Arg...· 0 citations
Systemic arterial hypertension is one of the main modifiable risk factors for cardiovascular diseases, and its control remains an important challenge for Primary Health Care. In this context, the present study aimed to analyze blood pressure control and cardiovascular risk among hypertensive patients followed in Primar...
Alcides Mendes da Luz, Vilmar Barbosa de Sousa, Adélia Dalva da Silva Oliveira· Revista ft· 0 citations
Systemic Lupus Erythematosus (SLE) is a multisystemic autoimmune pathology characterized by the production of autoantibodies that lead to severe organ damage, with lupus nephritis being the main responsible for the progression to terminal Chronic Kidney Disease (CKD). The objective of this study is to analyze the proce...
Mayra Elizabeth Condor Laica, Ricardo Rosendo Amaya Cordova, Luís Adrián Loor Cedeño et al.· Tesla Revista Científica· 0 citations
The impact of arterial hypertension on patient quality of life has established a critical need for comprehensive intervention within primary healthcare units. Consequently, it is essential to determine frequent mood alterations and somatic manifestations in hypertensive patients through the application of the CHAL (Cue...
Fanny Piedad Villa Piray, Susana Padilla-Buñay· Salud Medicina e Innovación...· 0 citations
ABSTRACT:
The cardiovascular-kidney-metabolic (CKM) syndrome is a comprehensive clinical framework proposed in 2023 by the American Heart Association. This approach describes how the pathophysiological interconnections between adipose tissue accumulation or dysfunction, metabolic risk factors, chronic kidney damage, a...
Telmo Eduardo Salas Joya, Leonardo Lanzee Mendoza Jiménez, Oscar Santiago Palomeque Teran et al.· VitalyScience Revista Cientí...· 0 citations
Type 2 diabetes mellitus is one of the major public health challenges worldwide due to its high prevalence, chronic progression, and association with complications that increase morbidity, mortality, and healthcare costs. In this context, metabolic control is a central goal of therapeutic management, with nutritional i...
Dayana Carolina Carrión Prado, Paul Alexander Orellana Añazco· Salud Medicina e Innovación...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.